Guerra-Amor A, Lopez-Gonzalez A, Pau Bosch-Nicolau* and Molina I
In this report, we present a case of visceral leishmaniasis in a patient with multiple sclerosis (MS) under fingolimod treatment. We discuss the previously published cases of MS patients under different immunosuppressant therapies to highlight its risk in endemic areas and suggest a therapeutic approach.